dc.contributor.author | Kantor, Rami | |
dc.contributor.author | Diero, Lameck | |
dc.contributor.author | DeLong, Allison | |
dc.contributor.author | Kamle, Lydia | |
dc.contributor.author | Muyonga, Sarah | |
dc.contributor.author | Mambo, Fidelis | |
dc.contributor.author | Emonyi, Wilfred | |
dc.contributor.author | Chan, Philip | |
dc.contributor.author | Carter, Jane | |
dc.contributor.author | Hogan, Joseph | |
dc.contributor.author | Buziba, Nathan | |
dc.contributor.author | Walumbe, Eunice | |
dc.date.accessioned | 2020-03-12T12:40:46Z | |
dc.date.available | 2020-03-12T12:40:46Z | |
dc.date.issued | 2009-08-01 | |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/3016 | |
dc.description.abstract | The monitoring of patients with human immunodeficiency virus (HIV) infection who are treated with antiretroviral medications in resource-limited settings is typically performed by use of clinical and immunological criteria. The early identification of first-line antiretroviral treatment failure is critical to prevent morbidity, mortality, and drug resistance. Misclassification of failure may result in premature switching to second-line therapy | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ampath Publications | en_US |
dc.subject | Misclassification | en_US |
dc.subject | First-Line | en_US |
dc.subject | Antiretroviral Treatment | en_US |
dc.subject | Resource-Limited Settings | en_US |
dc.subject | Immunological | en_US |
dc.subject | Monitoring of HIV | en_US |
dc.title | Misclassification of First-Line Antiretroviral Treatment Failure Based on Immunological Monitoring of HIV Infection in Resource-Limited Settings | en_US |
dc.type | Article | en_US |